Oramed Pharmaceuticals, Inc. (ORMP)
3.39
-0.23
(-6.35%)
USD |
NASDAQ |
Mar 05, 16:00
3.39
0.00 (0.00%)
After-Hours: 17:42
Oramed Pharmaceuticals Cash from Investing (TTM) : 23.22M for Sept. 30, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Lifeward Ltd. | -0.005M |
| Bristol Myers Squibb Co. | -4.132B |
| Merck & Co., Inc. | -13.74B |
| Instil Bio, Inc. | 30.66M |
| Moderna, Inc. | 1.946B |